Change in Portal Pressure and Clinical Outcome in Cirrhotic Patients with Gastric Varices after Plug-Assisted Retrograde Transvenous Obliteration
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Plug-assisted retrograde transvenous obliteration (PARTO) is widely used to manage gastric varices with a portosystemic shunt. It is not clear whether portal pressure and the incidence of complications increase after PARTO. The aim of this study was to determine the changes in portal pressure and the associated changes in liver function, ascites, hepatic encephalopathy, and especially esophageal varix (EV) after PARTO. Methods: From March 2012 to February 2018, 54 patients who underwent PARTO were analyzed retrospectively. The parameters collected included liver function and episodes of cirrhotic complications before and at 1 and 6 months after PARTO. Results: The analysis of 54 patients showed improvement in liver function during the 6-month follow-up period (Model for End-Stage Liver Disease score: change from 11.46±4.35 to 10.33±2.96, p=0.021). Among these 54 patients, 25 patients were evaluated for their hepatic venous pressure gradient (HVPG) before and after PARTO (change from 12.52±3.83 to 14.68±5.03 mm Hg; p<0.001). Twenty-five patients with portal pressure measured before and after PARTO were evaluated for risk factors affecting liver function improvement and EV deterioration. No factor associated with portal pressure was affected by liver function improvement. Post-PARTO portal pressure was a risk factor affecting EV deterioration (HVPG-post: odds ratio, 1.341; 95% confidence interval, 1.017 to 1.767; p=0.037). Conclusions: The artificial blockade of the portosystemic shunt evidently leads to an increase in HVPG. Liver function was improved over the 6-month follow-up period. Portal pressure after PARTO was a significant risk factor for EV deterioration. Portal pressure measurement is helpful for predicting the patient’s clinical outcome.
Abstract
Background/Aims: Plug-assisted retrograde transvenous obliteration (PARTO) is widely used to manage gastric varices with a portosystemic shunt. It is not clear whether portal pressure and the incidence of complications increase after PARTO. The aim of this study was to determine the changes in portal pressure and the associated changes in liver function, ascites, hepatic encephalopathy, and especially esophageal varix (EV) after PARTO. Methods: From March 2012 to February 2018, 54 patients who underwent PARTO were analyzed retrospectively. The parameters collected included liver function and episodes of cirrhotic complications before and at 1 and 6 months after PARTO. Results: The analysis of 54 patients showed improvement in liver function during the 6-month follow-up period (Model for End-Stage Liver Disease score: change from 11.46±4.35 to 10.33±2.96, p=0.021). Among these 54 patients, 25 patients were evaluated for their hepatic venous pressure gradient (HVPG) before and after PARTO (change from 12.52±3.83 to 14.68±5.03 mm Hg; p<0.001). Twenty-five patients with portal pressure measured before and after PARTO were evaluated for risk factors affecting liver function improvement and EV deterioration. No factor associated with portal pressure was affected by liver function improvement. Post-PARTO portal pressure was a risk factor affecting EV deterioration (HVPG-post: odds ratio, 1.341; 95% confidence interval, 1.017 to 1.767; p=0.037). Conclusions: The artificial blockade of the portosystemic shunt evidently leads to an increase in HVPG. Liver function was improved over the 6-month follow-up period. Portal pressure after PARTO was a significant risk factor for EV deterioration. Portal pressure measurement is helpful for predicting the patient’s clinical outcome.
참고문헌 (28)
- Al-Osaimi AM, "Medical and endoscopic management of gastric varices", Semin Intervent Radiol, 28, pp.273~282 (2011)
- Sarin SK, "Prevalence, classification and natural history of gastric varices : a longterm follow-up study in 568 portal hypertension patients", Hepatology, 16, pp.1343~1349 (1992)
- Yeon Seok Seo, "Prevention and management of gastroesophageal varices", Clinical and Molecular Hepatology, 24(1), pp.20~42 (2018), 대한간학회
- Triantafyllou M, "Update on gastric varices", World J Gastrointest Endosc, 6, pp.168~175 (2014)
- Trudeau W, "Endoscopic injection sclerosis in bleeding gastric varices", Gastrointest Endosc, 32, pp.264~268 (1986)
- Kanagawa H, "Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration", J Gastroenterol Hepatol, 11, pp.51~58 (1996)
- Matsumoto A, "Balloon-occluded retrograde transvenous obliteration of high risk gastric fundal varices", Am J Gastroenterol, 94, pp.643~649 (1999)
- Ninoi T, "Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt : long-term follow-up in 78 patients", AJR Am J Roentgenol, 184, pp.1340~1346 (2005)
- Cho SK, "Balloon-occluded retrograde transvenous obliteration of gastric varices : outcomes and complications in 49 patients", AJR Am J Roentgenol, 189, pp.W365~W372 (2007)
- 장세영, "Clinical outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage in Korean patients with liver cirrhosis: a retrospective multicenter study", Clinical and Molecular Hepatology, 18(4), pp.368~374 (2012), 대한간학회[DOI]
- 장민영, "Plug-Assisted Retrograde Transvenous Obliteration for the Treatment of Gastric Variceal Hemorrhage", Korean Journal of Radiology, 17(2), pp.230~238 (2016), 대한영상의학회[DOI]
- Kawanaka H, "Portosystemic encephalopathy treated with balloon-occluded retrograde transvenous obliteration", Am J Gastroenterol, 90, pp.508~510 (1995)
- Akahane T, "Changes in liver function parameters after occlusion of gastrorenal shunts with balloonoccluded retrograde transvenous obliteration", Am J Gastroenterol, 92, pp.1026~1030 (1997)
- Uehara H, "Prediction of improved liver function after balloon-occluded retrograde transvenous obliteration : relation to hepatic vein pressure gradient", J Gastroenterol Hepatol, 27, pp.137~141 (2012)
- Gwon DI, "Vascular plug-assisted retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy : a prospective multicenter study", J Vasc Interv Radiol, 26, pp.1589~1595 (2015)
- Kessler J, "Use of the Amplatzer Vascular Plug for embolization of a large retroperitoneal shunt during transjugular intrahepatic portosystemic shunt creation for gastric variceal bleeding", J Vasc Interv Radiol, 17, pp.135~140 (2006)
- Shimoda R, "Short-term complications of retrograde transvenous obliteration of gastric varices in patients with portal hypertension : effects of obliteration of major portosystemic shunts", Abdom Imaging, 30, pp.306~313 (2005)
- Park SJ, "The prevalence, risk factors, and clinical outcome of balloon rupture in balloonoccluded retrograde transvenous obliteration of gastric varices", J Vasc Interv Radiol, 21, pp.503~507 (2010)
- Gwon DI, "Gastric varices and hepatic encephalopathy : treatment with vascular plug and gelatin spongeassisted retrograde transvenous obliteration : a primary report", Radiology, 268, pp.281~287 (2013)
- Lee E, "Comparison of hepatic venous pressure gradient and endoscopic grading of esophageal varices", World J Gastroenterol, 22, pp.3212~3219 (2016)
- Fukuda T, "Long-term results of balloonoccluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy", J Vasc Interv Radiol, 12, pp.327~336 (2001)
- Hiraga N, "The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration", J Gastroenterol, 42, pp.663~672 (2007)
- Jogo A, "Factors associated with aggravation of esophageal varices after B-RTO for gastric varices", Cardiovasc Intervent Radiol, 37, pp.1243~1250 (2014)
- Kumamoto M, "Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices : hepatic deterioration links to portosystemic shunt syndrome", J Gastroenterol Hepatol, 25, pp.1129~1135 (2010)
- 최영호, "Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Variceal Bleeding:Its Feasibility Compared with Transjugular Intrahepatic Portosystemic Shunt", Korean Journal of Radiology, 4(2), pp.6~116 (2003), 대한영상의학회
- Sonomura T, "Balloon-occluded retrograde transvenous obliteration for gastric varices : a feasibility study", Cardiovasc Intervent Radiol, 21, pp.27~30 (1998)
- Park JK, "Vascular plug-assisted retrograde transvenous obliteration of portosystemic shunts for refractory hepatic encephalopathy : a case report", Case Rep Radiol, 2014, pp.391420~ (2014)
- Hong CH, "Treatment of patients with gastric variceal hemorrhage : endoscopic N-butyl-2-cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration", J Gastroenterol Hepatol, 24, pp.372~378 (2009)